SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

NewAmsterdam Pharma Reports Third-Quarter Financial Results

SquawkNews Desk 3 updates Updated Nov 04, 2026, 12:38 PM UTC

Story updates

12:31:47 PM UTC
SquawkNews
Received European Commission approval for Ubeslo® (obicetrapib monotherapy) and Evlarco® (obicetra
12:32:22 PM UTC
SquawkNews
NewAmsterdam Pharma 3Q Loss/Shr 14c >NAMS
12:38:43 PM UTC
SquawkNews
NewAmsterdam Pharma: Nettoverlust im dritten Quartal 2026 sinkt zum Vorjahr um 76 Prozent auf 17.39

Related stories

Nooks Secures $500M and Launches AI Sales Assistant Node M impact | EQUITY | Nov 04, 2026, 02:10 PM UTC Wall Street Set for Higher Open After Democrats Win Congress U.S. stocks were poised to open higher after Democrats secured sweeping victories in the midterm elections, as investors expected divided government to limit sharp policy shifts. M impact | EQUITY | Nov 04, 2026, 01:57 PM UTC Wall Street Futures Rise as Data Center Stocks Slide US stock futures were up, while data center stocks fell. The headline attributes the higher open to Democrats winning Congress. M impact | EQUITY | Nov 04, 2026, 01:57 PM UTC Brookfield Renewable Partners Q3 2026 Earnings Call Begins Brookfield Renewable Partners’ Q3 2026 earnings call has begun. M impact | EQUITY | Nov 04, 2026, 01:57 PM UTC Vermilion Energy Q3 2026 Earnings Call Begins Vermilion Energy's quarterly earnings call has begun. M impact | EQUITY | Nov 04, 2026, 01:57 PM UTC International Flavors & Fragrances Begins Q3 2026 Earnings Call International Flavors & Fragrances' quarterly earnings call has begun. M impact | EQUITY | Nov 04, 2026, 01:57 PM UTC